Impact on regional recurrence and survival of axillary surgery in women with node-negative primary breast cancer
✍ Scribed by C. K. Axelsson; M. Düring; P. M. Christiansen; P. A. Wamberg; K. L. Søe; S. Møller
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 119 KB
- Volume
- 96
- Category
- Article
- ISSN
- 0007-1323
- DOI
- 10.1002/bjs.6350
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background
This study examined whether axillary lymph node dissection (ALND) with removal of many normal lymph nodes resulted in a reduced rate of axillary recurrence and better survival, as reported in recent studies.
Methods
The follow-up analyses were based on 8657 patients with node-negative primary breast cancer treated solely by surgery. Median follow-up was 9 years.
Results
The number of lymph nodes removed correlated with a reduction in the rate of subsequent axillary recurrence (from 2·1 to 0·4 per cent; P = 0·037), local recurrence (from 7·4 to 3·8 per cent; P < 0·001) distant metastases (from 15·0 to 10·3 per cent; P < 0·001) and death as first event (from 7·5 to 5·5 per cent; P = 0·012).
Conclusion
When ALND is indicated, at least ten axillary lymph nodes should be retrieved. The role of ALND as primary treatment has decreased significantly during the past decade. The findings leave the concept of the sentinel node biopsy intact, as a highly specific procedure compared to ALND.
📜 SIMILAR VOLUMES
## Abstract ## Background Adjuvant trastuzumab for small, node-negative, human epidermal growth factor receptor 2 (HER2)-positive breast cancer remains controversial. The purpose of this study was to investigate the risk of recurrence in women with pathological tumour node (pTN) T1 N0 tumours. ##